Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialNicole Basset‐Séguin, Johan Hansson, Brigitte Dréno et al.|European Journal of Cancer|2017Cited by 284
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset‐Séguin, Johan Hansson, L. Thomas et al.|The Lancet Oncology|2015Cited by 244
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016Christian Dittrich, Rainer Kunstfeld, Gunta Purkalne et al.|ESMO Open|2016Cited by 129
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Axel Hauschild, Brigitte Dréno et al.|European Journal of Dermatology|2018Cited by 26
Impact of treatment breaks on vismodegib patient outcomes: Exploratory analysis of the STEVIE study.Reinhard Dummer, Axel Hauschild, Brigitte Dréno et al.|Journal of Clinical Oncology|2015Cited by 22